Bevacizumab-induced hypertension in patients with glioblastoma: a systematic review and meta-analysis
Eur. heart j; 45 (Suppl. 1), 2024
BACKGROUND: Bevacizumab is a monoclonal antibody medication used as standard treatment for different types of cancers, one of them is glioblastoma, which is the most common primary brain tumor. PURPOSE: We aimed to assess bevacizumab and its effects on inducing hypertension in patients with glioblastoma....